Promising study results thrust Viking Therapeutics into race for lucrative fatty liver...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 18, 2018 at 10:22 AM.

  1. #1 cafead, Sep 18, 2018 at 10:22 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via An experimental pill from Viking Therapeutics (VKTX) reduced liver fat in patients with early signs of fatty liver disease, according to results from a mid-stage clinical trial announced Tuesday.

    article source
     
    Quote

Reply to Thread